Literature DB >> 19005038

Inherited neuronal ion channelopathies: new windows on complex neurological diseases.

William A Catterall1, Sulayman Dib-Hajj, Miriam H Meisler, Daniela Pietrobon.   

Abstract

Studies of genetic forms of epilepsy, chronic pain, and migraine caused by mutations in ion channels have given crucial insights into molecular mechanisms, pathogenesis, and therapeutic approaches to complex neurological disorders. Gain-of-function missense mutations in the brain type-I sodium channel Na(V)1.1 are a primary cause of generalized epilepsy with febrile seizures plus. Loss-of-function mutations in Na(V)1.1 channels cause severe myoclonic epilepsy of infancy, an intractable childhood epilepsy. Studies of a mouse model show that this disease is caused by selective loss of sodium current and excitability of GABAergic inhibitory interneurons, which leads to hyperexcitability, epilepsy, and ataxia. Mutations in the peripheral sodium channel Na(V)1.7 cause familial pain syndromes. Gain-of-function mutations cause erythromelalgia and paroxysmal extreme pain disorder as a result of hyperexcitability of sensory neurons, whereas loss-of-function mutations cause congenital indifference to pain because of attenuation of action potential firing. These experiments have defined correlations between genotype and phenotype in chronic pain diseases and focused attention on Na(V)1.7 as a therapeutic target. Familial hemiplegic migraine is caused by mutations in the calcium channel, Ca(V)2.1, which conducts P/Q-type calcium currents that initiate neurotransmitter release. These mutations increase activation at negative membrane potentials and increase evoked neurotransmitter release at cortical glutamatergic synapses. Studies of a mouse genetic model show that these gain-of-function effects lead to cortical spreading depression, aura, and potentially migraine. Overall, these experiments indicate that imbalance in the activity of excitatory and inhibitory neurons is an important underlying cause of these diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19005038      PMCID: PMC3177942          DOI: 10.1523/JNEUROSCI.3901-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  84 in total

1.  A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons.

Authors:  Anthony M Rush; Sulayman D Dib-Hajj; Shujun Liu; Theodore R Cummins; Joel A Black; Stephen G Waxman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-15       Impact factor: 11.205

2.  Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons.

Authors:  J J Toledo-Aral; B L Moss; Z J He; A G Koszowski; T Whisenand; S R Levinson; J J Wolf; I Silos-Santiago; S Halegoua; G Mandel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  Absence epilepsy in tottering mutant mice is associated with calcium channel defects.

Authors:  C F Fletcher; C M Lutz; T N O'Sullivan; J D Shaughnessy; R Hawkes; W N Frankel; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

4.  Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.

Authors:  R A Ophoff; G M Terwindt; M N Vergouwe; R van Eijk; P J Oefner; S M Hoffman; J E Lamerdin; H W Mohrenweiser; D E Bulman; M Ferrari; J Haan; D Lindhout; G J van Ommen; M H Hofker; M D Ferrari; R R Frants
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

5.  De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study.

Authors:  Samuel F Berkovic; Louise Harkin; Jacinta M McMahon; James T Pelekanos; Sameer M Zuberi; Elaine C Wirrell; Deepak S Gill; Xenia Iona; John C Mulley; Ingrid E Scheffer
Journal:  Lancet Neurol       Date:  2006-06       Impact factor: 44.182

6.  Spatial distribution of synaptically activated sodium concentration changes in cerebellar Purkinje neurons.

Authors:  J C Callaway; W N Ross
Journal:  J Neurophysiol       Date:  1997-01       Impact factor: 2.714

7.  Heterozygosity for a protein truncation mutation of sodium channel SCN8A in a patient with cerebellar atrophy, ataxia, and mental retardation.

Authors:  M M Trudeau; J C Dalton; J W Day; L P W Ranum; M H Meisler
Journal:  J Med Genet       Date:  2005-10-19       Impact factor: 6.318

8.  Relative contributions of axonal and somatic Na channels to action potential initiation in cerebellar Purkinje neurons.

Authors:  Zayd M Khaliq; Indira M Raman
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

9.  Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2.

Authors:  Jennifer A Kearney; Yan Yang; Barbara Beyer; Sarah K Bergren; Lieve Claes; Peter Dejonghe; Wayne N Frankel
Journal:  Hum Mol Genet       Date:  2006-02-07       Impact factor: 6.150

10.  An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability.

Authors:  Arthur J Barela; Salina P Waddy; Jay G Lickfett; Jessica Hunter; Aimee Anido; Sandra L Helmers; Alan L Goldin; Andrew Escayg
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

View more
  90 in total

1.  μ-conotoxin KIIIA derivatives with divergent affinities versus efficacies in blocking voltage-gated sodium channels.

Authors:  Min-Min Zhang; Tiffany S Han; Baldomero M Olivera; Grzegorz Bulaj; Doju Yoshikami
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

2.  Effect of sodium channel abundance on Drosophila development, reproductive capacity and aging.

Authors:  Graham Garber; Lee Ann Smith; Robert A Reenan; Blanka Rogina
Journal:  Fly (Austin)       Date:  2012-01-01       Impact factor: 2.160

Review 3.  The ß subunit of voltage-gated Ca2+ channels.

Authors:  Zafir Buraei; Jian Yang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

4.  Location, location, regulation: a novel role for β-spectrin in the heart.

Authors:  Kevin J Sampson; Robert S Kass
Journal:  J Clin Invest       Date:  2010-09-27       Impact factor: 14.808

5.  Characterization of the Functional Domains of a Mammalian Voltage-Sensitive Phosphatase.

Authors:  Mario G Rosasco; Sharona E Gordon; Sandra M Bajjalieh
Journal:  Biophys J       Date:  2015-12-15       Impact factor: 4.033

6.  The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction.

Authors:  Albert Y Sun; Jason I Koontz; Svati H Shah; Jonathan P Piccini; Kent R Nilsson; Damian Craig; Carol Haynes; Simon G Gregory; Patrick M Hranitzky; Geoffrey S Pitt
Journal:  Circ Cardiovasc Genet       Date:  2011-04-15

7.  Modeling human epilepsy by TALEN targeting of mouse sodium channel Scn8a.

Authors:  Julie M Jones; Miriam H Meisler
Journal:  Genesis       Date:  2013-12-12       Impact factor: 2.487

8.  Identification of the benzyloxyphenyl pharmacophore: a structural unit that promotes sodium channel slow inactivation.

Authors:  Amber M King; Xiao-Fang Yang; Yuying Wang; Erik T Dustrude; Cindy Barbosa; Michael R Due; Andrew D Piekarz; Sarah M Wilson; Fletcher A White; Christophe Salomé; Theodore R Cummins; Rajesh Khanna; Harold Kohn
Journal:  ACS Chem Neurosci       Date:  2012-09-19       Impact factor: 4.418

9.  Fluorescent saxitoxins for live cell imaging of single voltage-gated sodium ion channels beyond the optical diffraction limit.

Authors:  Alison E Ondrus; Hsiao-lu D Lee; Shigeki Iwanaga; William H Parsons; Brian M Andresen; W E Moerner; J Du Bois
Journal:  Chem Biol       Date:  2012-07-27

10.  Fine mapping of an epilepsy modifier gene on mouse Chromosome 19.

Authors:  Sarah K Bergren; Elizabeth D Rutter; Jennifer A Kearney
Journal:  Mamm Genome       Date:  2009-06-10       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.